top of page
Industry-Sponsored Events
Thursday, June 1, 2023
5:30 – 6:15 PM PT
First and Only FDA-Approved Eosinophilic Esophagitis (EoE) Treatment
Brooks D. Cash, MD, FACG, AGAF, FASGE
Chief, Gastroenterology, Hepatology, and Nutrition
University of Texas Health Science Center at Houston
Houston, TX
Sponsored by:
Friday, June 2, 2023
12:45 – 1:30 PM PT
RISE ABOVE RECURRENT C. DIFFICILE INFECTION with REBYOTA™
The first and only FDA-approved microbiota-based live biotherapeutic to prevent recurrence of C. difficile infection starting at first recurrence
Daniel Van Handel, MD
Gastroenterologist
Minnesota Gastroenterology Digestive Health (MNGI)
Sponsored by:
![Ferring logo extensions_MICROBIOME[3].png](https://static.wixstatic.com/media/dcb143_dfa5a71d7ee940cd830e599392c9046c~mv2.png/v1/fill/w_299,h_78,al_c,q_85,usm_0.66_1.00_0.01,enc_auto/Ferring%20logo%20extensions_MICROBIOME%5B3%5D.png)
Saturday, June 3, 2023
7:30 – 8:15 AM PT
An Innovative Approach for the Treatment of Adults With Irritable Bowel Syndrome
With Constipation (IBS-C)
Kavita Kongara, MD
Gastroenterologist Atlanta
Gastroenterology Director of Motility
Services Northside Hospital
Atlanta, GA
Sponsored by:
bottom of page